Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Maheu-Giroux

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
The International Journal on Drug Policy|July 3, 2021
Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?Charlotte Lanièce Delaunay, Arnaud Godin, Nadine Kronfli, et al.
The International Journal on Drug Policy|January 8, 2018
Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and RussiaIsabel Tavitian-Exley, Mathieu Maheu-Giroux, Lucy Platt, et al.
BMC Pregnancy and Childbirth|April 22, 2016
Risk factors for vaginal fistula symptoms in Sub-Saharan Africa: a pooled analysis of national household survey dataMathieu Maheu-Giroux, Véronique Filippi, Nathalie Maulet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 5, 2017
Changing Dynamics of HIV Transmission in Côte d'Ivoire: Modeling Who Acquired and Transmitted Infections and Estimating the Impact of Past HIV Interventions (1976-2015)Mathieu Maheu-Giroux, Juan F Vesga, Souleymane Diabaté, et al.
The International Journal on Drug Policy|April 19, 2023
Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling studyCharlotte Lanièce Delaunay, Marina B Klein, Arnaud Godin, et al.
Plos Medicine|June 16, 2017
Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modelingMathieu Maheu-Giroux, Juan F Vesga, Souleymane Diabaté, et al.
BMJ Open|June 29, 2019
Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, CanadaZoë R Greenwald, Mathieu Maheu-Giroux, Jason Szabo, et al.
AIDS and Behavior|May 28, 2021
Under-Reporting of Known HIV-Positive Status Among People Living with HIV: A Systematic Review and Meta-analysisNirali Soni, Katia Giguère, Marie-Claude Boily, et al.
Journal of the International AIDS Society|August 14, 2025
Socio-demographic and geographic disparities in HIV prevalence, HIV testing and treatment coverage: An analysis of 108 national household surveys in 33 African countriesAdrien Allorant, Salome Kuchukhidze, James Stannah, et al.
Acta Tropica|March 2, 2010
Risk of malaria transmission from fish ponds in the Peruvian AmazonMathieu Maheu-Giroux, Martín Casapía, Veronica E Soto-Calle, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
The International Journal on Drug Policy|July 3, 2021
Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?Charlotte Lanièce Delaunay, Arnaud Godin, Nadine Kronfli, et al.
The International Journal on Drug Policy|January 8, 2018
Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and RussiaIsabel Tavitian-Exley, Mathieu Maheu-Giroux, Lucy Platt, et al.
BMC Pregnancy and Childbirth|April 22, 2016
Risk factors for vaginal fistula symptoms in Sub-Saharan Africa: a pooled analysis of national household survey dataMathieu Maheu-Giroux, Véronique Filippi, Nathalie Maulet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 5, 2017
Changing Dynamics of HIV Transmission in Côte d'Ivoire: Modeling Who Acquired and Transmitted Infections and Estimating the Impact of Past HIV Interventions (1976-2015)Mathieu Maheu-Giroux, Juan F Vesga, Souleymane Diabaté, et al.
The International Journal on Drug Policy|April 19, 2023
Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling studyCharlotte Lanièce Delaunay, Marina B Klein, Arnaud Godin, et al.
Plos Medicine|June 16, 2017
Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modelingMathieu Maheu-Giroux, Juan F Vesga, Souleymane Diabaté, et al.
BMJ Open|June 29, 2019
Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, CanadaZoë R Greenwald, Mathieu Maheu-Giroux, Jason Szabo, et al.
AIDS and Behavior|May 28, 2021
Under-Reporting of Known HIV-Positive Status Among People Living with HIV: A Systematic Review and Meta-analysisNirali Soni, Katia Giguère, Marie-Claude Boily, et al.
Journal of the International AIDS Society|August 14, 2025
Socio-demographic and geographic disparities in HIV prevalence, HIV testing and treatment coverage: An analysis of 108 national household surveys in 33 African countriesAdrien Allorant, Salome Kuchukhidze, James Stannah, et al.
Acta Tropica|March 2, 2010
Risk of malaria transmission from fish ponds in the Peruvian AmazonMathieu Maheu-Giroux, Martín Casapía, Veronica E Soto-Calle, et al.
Pageof 14